Pharmafile Logo

Sharing Outcomes in MS at ECTRIMS 2023

October 9, 2023 | Medscape, medical education, outcomes 

- PMLiVE

During ECTRIMS 2023 congress, the Medscape Education Global team will be on site to present a poster of their educational outcomes.

The poster, Virtual Patient Simulation Improves Neurologists’ Performance in Making Appropriate Clinical Decisions for Patients With Multiple Sclerosis, covers the outcomes and impact of a Medscape virtual patient simulation, which allows learners to participate in a realistic patient care practice experience.

The Medscape program achieved significant success in improving performance on MS treatment.

“Virtual patient simulation is a great, immersive way to learn. We’re excited to share this poster that demonstrates the improvements in performance this learning format can have, and the benefit to patients living with MS,” said S. Christy Rohani-Montez, Ph.D. Director of Clinical Strategy, Medscape Education.

Medscape will also host a social event for conference attendees in a nearby restaurant. The event will feature Medscape faculty member Tjalf Ziemssen, MD, and allow participants to enjoy light refreshments as they discuss the latest developments in MS treatment and research.

For questions or to RSVP don’t hesitate to get in touch with your Medscape representative or Ashleigh Bean at abean@webmd.net / +44 7894 242243.

For more information on Medscape Education Global’s education in neurology or on MS, please contact. S. Christy Rohani-Montez.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...